Key Takeaways
- New data presented at the European Congress on Obesity (ECO2026, Istanbul, May 12-15, 2026) shows roughly 80-85% of GLP-1 weight loss is fat mass and that relative skeletal muscle mass is preserved or increased in over 70% of patients.
- Up to 25-40% of total weight loss on a GLP-1 can come from lean body mass when patients eat too little protein and skip resistance training. That is not a drug problem - it is a prescription problem.
- Protein dose matters: 1.2-1.6 g/kg/day (roughly 25-30 g per meal) is the floor for adults losing weight on a GLP-1. Older adults and athletes should anchor toward the higher end.
- Resistance training 2-3 days per week is non-negotiable. Cardio is excellent for cardiometabolic health but does not preserve muscle during caloric deficit.
- Pharmacologic muscle-sparing agents (bimagrumab, in the BELIEVE Phase 2b trial) are an emerging adjunct - but real-world muscle preservation today depends on protein, training, and clinical oversight.
The Hook: ECO2026 Just Quieted the Muscle-Loss Panic
If you have read a single fitness blog in the past year, you have seen the warning: 'Ozempic eats your muscle.' Last week at the European Congress on Obesity in Istanbul (ECO2026, May 12-15, 2026), the latest body-composition data on GLP-1 receptor agonists told a more nuanced story. In one analysis, fat mass fell by roughly 9 kg (about 18%) while skeletal muscle mass fell by 1.2 kg (about 5%) - and over 70% of patients actually preserved or increased their relative muscle mass. The American Council on Science and Health called it 'The GLP-1s' Great Muscle Scare' on May 14, 2026, and they are right that the panic outran the science.
But there is a real signal underneath the noise. Without protein and resistance training, lean mass losses can climb to 25-40% of total weight loss on a high-efficacy GLP-1. That is the difference between a 50-year-old patient who loses 35 lb and looks and moves better, and the same patient who loses 35 lb and falls getting out of a chair at 70. As a physician who has built a clinical weight-loss program with VRP Sciences and P.O.W., my job is to make sure my patients are in the first group.
The Science: What's Actually Happening to Your Muscle on a GLP-1
GLP-1 receptor agonists - semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and now oral and triple-agonist agents - work by amplifying postprandial GLP-1 signaling. They slow gastric emptying, blunt the post-meal glucagon spike, and dial down central reward circuitry. The result is a 12-22% body-weight reduction over 68-72 weeks in the SURMOUNT and STEP trials, and even larger in the TRIUMPH retatrutide program. The mechanism that drives the weight loss - profound caloric restriction - is also the mechanism that puts muscle at risk.
Two pieces of physiology matter here. First, leucine-triggered muscle protein synthesis. Skeletal muscle needs a leucine threshold (roughly 2.5-3 g of leucine, equivalent to 25-30 g of high-quality protein) per meal to maximally stimulate mTORC1 and the muscle-building cascade. When appetite collapses on a GLP-1 and people graze on yogurt and crackers, they miss that threshold all day long. Second, mechanical loading. Muscle responds to demand. Strip away resistance training and you remove the signal that says 'keep this tissue.' The body, sensing low calories and low demand, sells the tissue back for energy.
The ECO2026 data, the new Cell Reports Medicine paper, and the BELIEVE bimagrumab/semaglutide Phase 2 trial all converge on the same conclusion: GLP-1s do not specifically attack muscle. They just unmask whether the patient is doing the work to defend it. In BELIEVE, semaglutide alone reduced lean mass by 7.4%; bimagrumab plus semaglutide cut that loss to 2.9% and increased the fat-mass fraction of weight loss to over 90%. Drug science is catching up, but it is not a substitute for protein and a barbell.
The Leucine Factor: Why I Wrote This Book Twelve Years Ago
In The Leucine Factor Diet, I argued that adults pursuing body recomposition need to anchor each meal around a meaningful dose of high-quality protein - not because protein is magic but because leucine is the signal molecule that protects muscle while the rest of the body burns fat. That argument was directed at competitive bodybuilders and dieting athletes in 2014. In 2026, with a third of my patient population on a GLP-1, it is more clinically urgent than ever. The patients who do best on tirzepatide or oral GLP-1s in my clinic are the ones who hit 30 g of protein per meal, lift heavy two or three times a week, and titrate the medication carefully so they can still eat real food.
The Solution at P.O.W. and P.O.W. Fit
Our medically supervised weight-loss program at Prisk Orthopaedics and Wellness is specifically designed to avoid the sarcopenia trap. Here is what a typical patient gets:
- Baseline body composition: Ultrasound guided fat testing and, when indicated, DEXA - so we know your starting lean mass before the first injection.
- Protein prescription: a personalized target in the 1.4-1.8 g/kg/day range, broken into 25-35 g servings across 3-4 meals, with whey or animal protein preferred for leucine density.
- Resistance training plan: 2-3 sessions per week, anchored on compound lifts (squat, hinge, push, pull) progressed by load. We coordinate with Power Performance Physical Therapy and our P.O.W.Fit programming.
- Pharmacology: thoughtful titration of semaglutide, tirzepatide, or oral GLP-1 agents - and we are watching the bimagrumab and survodutide pipelines closely.
- Repeat composition scanning every 8-12 weeks. If lean mass falls more than 10% of total loss, we change the prescription, not the patient.
Frequently Asked Questions
Will I lose muscle on Ozempic, Wegovy, Mounjaro, or Zepbound?
Some lean mass loss is normal with any meaningful weight loss - drug-induced or not. The new ECO2026 data show that with adequate protein and resistance training, the absolute lean mass loss averages around 5%, with relative muscle mass preserved or increased in more than 70% of patients. Without those interventions, lean mass losses can reach 25-40% of total weight loss.
How much protein do I need on a GLP-1?
Aim for 1.4-1.8 g/kg of total body weight per day (or per goal weight if you are deeply obese), divided into 3-4 meals of 25-35 g of high-quality protein each. Older adults, athletes, and patients losing more than 1% of body weight per week should anchor toward 1.4-1.6 g/kg/day.
Do I really need to lift weights?
Yes. Cardio is excellent for blood pressure, lipids, cardiorespiratory fitness, and quality of life - but it does not protect muscle during a caloric deficit. Resistance training 2-3 days a week, with progressive overload, is the single most effective non-pharmacologic intervention to preserve lean mass on a GLP-1.
What about bimagrumab and other muscle-sparing drugs?
Bimagrumab, a myostatin/activin-pathway inhibitor, when combined with semaglutide in the BELIEVE Phase 2b trial, cut lean mass loss from 7.4% to 2.9% and pushed the fat fraction of total weight loss above 90%. It is not FDA approved as a co-therapy yet and is not in routine clinical use. Watch this space - the trial readouts later in 2026 and 2027 will define whether it becomes mainstream.
Can I just take creatine and call it a day?
Creatine monohydrate (3-5 g/day) is a safe, evidence-based adjunct for muscle and strength preservation during weight loss. It is not a substitute for protein or training, but it stacks well with both.
What if I stop the GLP-1?
Most patients regain a meaningful fraction of weight after discontinuation. The muscle you preserve while on therapy is what carries your metabolism through the post-medication phase. The patients who taper well are the ones who showed up to the gym during therapy. See our companion piece, 'The Ozempic Off-Ramp,' on the P.O.W. blog.
Schedule with P.O.W.
If foot, ankle, or lower-extremity pain is keeping you off the field, ice, or stage, do not guess and do not Google your way through another season. Call Prisk Orthopaedics and Wellness, P.C. at (412) 525-7692 or book online at orthoandwellness.com. New patient evaluations typically available within a week.
About the Author
Victor R. Prisk, MD is a board-certified orthopaedic surgeon specializing in foot and ankle reconstruction and sports medicine, and is the CEO and Medical Director of Prisk Orthopaedics and Wellness, P.C. (P.O.W.) and its affiliated brands P.O.W.Fit and VRP Sciences. A former competitive bodybuilder and NCAA gymnast, he is the author of The Leucine Factor Diet and treats athletes from the recreational to the professional level. Dr. Prisk practices in the greater Pittsburgh region and accepts new patients at orthoandwellness.com.
